Psychedelics not linked to mental health problems or suicidal behavior: A population study

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens

(2015) Adam L. Halberstadt   BEHAVIOURAL BRAIN RESEARCH

‘Visual snow’ – a disorder distinct from persistent migraine aura

(2014) Christoph J. Schankin et al.   BRAIN

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

(2014) Peter S Hendricks et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction

(2014) Matthew W Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of Schedule I drug laws on neuroscience research and treatment innovation

(2013) David J. Nutt et al.   NATURE REVIEWS NEUROSCIENCE

Psychedelics and Mental Health: A Population Study

(2013) Teri S. Krebs et al.   PLoS One

A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students

(2012) Robert M. Hallock et al.   DRUG AND ALCOHOL DEPENDENCE

Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

(2012) Teri S Krebs et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

(2012) José Carlos Bouso et al.   PLoS One

Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland

(2012) Mark Taylor et al.   BMJ Open

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness

(2011) Katherine A MacLean et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

(2011) Roland R. Griffiths et al.   PSYCHOPHARMACOLOGY

Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative

(2010) Ronald C. Kessler et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

(2010) Erich Studerus et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Drug harms in the UK: a multicriteria decision analysis

(2010) David J Nutt et al.   LANCET

Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population

(2010) Jan van Amsterdam et al.   EUROPEAN ADDICTION RESEARCH

Harms associated with psychoactive substances: findings of the UK National Drug Survey

(2009) Celia JA Morgan et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY